The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
The Vita Coco Company, Inc. filing reports Michael Kirban beneficially owns 3,274,866 shares of Common Stock, representing 5.6% of the class.
The filing cites 57,112,643 shares outstanding as of April 27, 2026. The 3,274,866 total (as of April 7, 2026) equals 75,339 shares held directly, 1,154,797 exercisable options within 60 days, 1,479,049 shares held by the Michael Kirban 2010 Trust, and 565,681 shares held by the Michael Kirban Revocable Trust. The statement is signed by Michael Kirban on 05/15/2026.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an exercise-and-sale transaction in company stock. He exercised 30,000 shares of Common Stock at an exercise price of $10.178 per share through a non-qualified stock option and on the same date sold 30,000 shares in an open-market transaction at $75.00 per share. The sales were effected under a Rule 10b5-1 trading plan, indicating they were pre-arranged. Following these transactions, he directly holds 57,910 shares of Common Stock and retains multiple outstanding stock option awards, including options linked to 40,950 underlying shares at an exercise price of $10.178 expiring on February 10, 2030 and options linked to 34,125 underlying shares at an exercise price of $10.178 expiring on January 11, 2031.
COCO submitted a Form 144 reporting a proposed sale of 30,000 shares of Common Stock to be sold on 05/12/2026 under an option granted 02/10/2020. The filing also lists prior open-market sales by Jonathan Burth of 60,000; 40,000; 20,000; and 20,000 shares on 03/16/2026, 04/29/2026, 04/30/2026, and 05/08/2026, respectively, with proceeds shown for each transaction.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an exercise-and-sale transaction in company stock. He exercised stock options to acquire 20,000 shares of Common Stock at $10.178 per share, then sold 20,000 shares at $70.00 per share in an open-market transaction.
The sale was made under a Rule 10b5-1 trading plan, indicating it was pre-arranged rather than opportunistic. After the reported sale, Burth directly holds 57,910 shares of Common Stock. He also retains multiple outstanding non-qualified stock option awards with exercise prices ranging from $10.178 to $33.36 and expirations between 2030 and 2035, some of which vest over time or upon meeting performance conditions.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 8,561 shares of common stock at $70.0000 per share. After this transaction, he directly holds 67,130 shares of common stock.
The sale was effected under a Rule 10b5-1 trading plan, indicating it was pre-arranged. Van Es also continues to hold multiple non-qualified stock options to buy common stock, with exercise prices between $10.1780 and $33.3600 and expiration dates from 2030 through 2035.
COCO submitted a Form 144 notice reporting sales of Common Stock by Charles Van Es. The excerpt lists three dispositions: 2,000 shares on 03/16/2026 for $115,960, 2,000 shares on 04/01/2026 for $97,340, and 2,000 shares on 05/01/2026 for $133,740. The filing also lists several restricted stock vesting events issued as compensation on various dates, with unit counts shown.
Filer submitted a Form 144 reporting a proposed sale of 20,000 shares of Common Stock. The entry lists 20,000 shares with an aggregate amount of $1,400,000.00 and an "as of" date of 05/08/2026. The record also shows prior sales by Jonathan Burth of 60,000, 40,000, and 20,000 shares on 03/16/2026, 04/29/2026, and 04/30/2026 respectively with listed proceeds.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Vita Coco Company, Inc. director and Executive Chairman Michael Kirban reported an insider transaction involving a trust he is associated with. On the reported date, the Michael Kirban Revocable Trust sold 50,000 shares of common stock at $68.00 per share in an open‑market transaction carried out under a Rule 10b5‑1 trading plan. Following this sale, that revocable trust held 515,681 shares of Vita Coco common stock. Separately, the filing shows 1,479,049 shares of common stock held indirectly by the Michael Kirban 2010 Trust and 143,799 shares held directly, along with several blocks of non‑qualified stock options with exercise prices ranging from $10.178 to $32.78 per share and expirations between 2029 and 2035.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth executed an exercise-and-sell trading pattern under a Rule 10b5-1 trading plan. On April 29–30, 2026, he exercised options to acquire 60,000 shares of common stock at an exercise price of about $10.178 per share and sold 60,000 shares in open-market transactions at prices ranging from $62.50 to $67.50 per share. Following these transactions, he directly owns 57,910 shares of common stock and retains several non-qualified stock option awards with exercise prices between $10.178 and $33.36 per share expiring between 2030 and 2035.